#VisualAbstract: Beta-Blocker Interruption Resulted in Similar Outcomes to Continuation after Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this secondary analysis of the DECLARE-TIMI 58 trial, among 17,160 patients, dapagliflozin consistently reduced the risk of cardiovascular ...
1. Beta-blockers were commonly used in the treatment of coronary artery disease in the 1980s, though prior studies were inconclusive ...
1. Maternal use of β-2-adrenergic receptor (B2AR) agonist drugs was found to be associated with an increased risk for autism ...
Image: PD 1. After adjustments, use of vasodilators or ß-blockers were significantly associated with increased risk of early and late age-related macular degeneration (AMD), ...
Image: PD 1. Beta-blocker use was associated with no significant improvement in major cardiovascular adverse events (MACE) or all-cause mortality ...
Image: PD 1. Carvedilol significantly reduced mortality from cardiovascular causes and recurrent non-fatal MI. 2. While carvedilol treatment was associated ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.